Forge Therapeutics
2015
FOUNDED
PRIVATE
STATUS
Grant
LATEST DEAL TYPE
$11.1M
LATEST DEAL AMOUNT
13
INVESTORS
Description
Developer of an innovative drug discovery platform designed to offer novel antibiotics to treat multi-drug resistant bacteria. The company's platform develops small molecule inhibitors targeting metalloenzymes using gram-negative bacteria, enabling healthcare professionals to access various biochemical processes and biological catalysis.to treat diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 10578 Science Center Drive
- Suite 205
- San Diego, CA 92121
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Forge Therapeutics’s full profile, request a free trial.
Forge Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 03-Jan-2019 | $11.1M | 000.00 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A) | 01-Dec-2017 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 2. Grant | 26-Jul-2016 | $8.8M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Jan-2015 | Completed | Generating Revenue |
Forge Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Forge Therapeutics Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SelectX Pharmaceuticals | Venture Capital-Backed | Boston, MA | 00 | 000.00 | 00000000000 | 000.00 |
| 00000 000000000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000000 | 00000 |
| 000000000 | Accelerator/Incubator Backed | Basel, Switzerland | 0 | 00.000 | 0000000000 | 00.000 |
| 000000 00000000000 | Formerly VC-backed | San Jose, CA | 00 | 000.00 | 000000000 | 000.00 |
| 00000000 | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 0000000000. |
Forge Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Evotec | Corporation | Minority | 000 0000 | 000000 0 | ||
| Keiretsu Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| MagnaSci Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| MP Healthcare Venture Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Forge Therapeutics Executive Team (5)
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »Forge Therapeutics Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Brian Dorsey | Self | Board Member | 000 0000 | |
| Jeffrey Moore Ph.D | MP Healthcare Venture Management | Board Member | 000 0000 | |
| John Schmid | Self | Board Member | 000 0000 | |
| Jonathan Kabakoff | Alexandria Venture Investments | Board Observer | 000 0000 | |
| Mario Polywka Ph.D | Evotec | Board Member | 000 0000 |